The 18 kDa translocator protein, microglia and neuroinflammation

Brain Pathology

Volumn 24, Issue 6, 2014, Pages 631-653

  Liu, Guo Jun ^a,b,c   Middleton, Ryan J ^a   Hatty, Claire R ^b,c   Kam, Winnie Wai Ying ^a,b,c   Chan, Ronald ^b,c   Pham, Tien ^a   Harrison Brown, Meredith ^a,c   Dodson, Eoin ^a   Veale, Kelly ^c   Banati, Richard B ^a,b,c,d  

^a AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Ramaciotti Brain Imaging Centre   (Australia)

Author keywords

microglia; neuroinflammation; PBR111; PET; PK11195; TSPO

Indexed keywords

MONOMER; PROTEIN DERIVATIVE; RADIOLIGAND; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; TSPO PROTEIN, HUMAN;

ARTICLE; BINDING SITE; BIOENERGY; CELL CYCLE; CHOLESTEROL TRANSPORT; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NONHUMAN; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; STEROIDOGENESIS; ANIMAL; BRAIN; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; HUMANS; INFLAMMATION; MICROGLIA; NEUROIMMUNOMODULATION; RECEPTORS, GABA;

EID: 84912016664     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12196     Document Type: Article

References (185)

1. Adam D, (2002) Citation analysis: the counting house. Nature 415: 726-729.
2. Alenfall J, Kant R, Batra S, (1998) Cytotoxic effects of 125I-labeled PBZr ligand PK 11195 in prostatic tumor cells: therapeutic implications. Cancer Lett 134: 187-192.
3. Anholt RR, De Souza EB, Kuhar MJ, Snyder SH, (1985) Depletion of peripheral-type benzodiazepine receptors after hypophysectomy in rat adrenal gland and testis. Eur J Pharmacol 110: 41-46.
4. Anholt RR, De Souza EB, Oster-Granite ML, Snyder SH, (1985) Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. J Pharmacol Exp Ther 233: 517-526.
5. Anholt RR, Pedersen PL, De Souza EB, Snyder SH, (1986) The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem 261: 576-583.
6. Antkiewicz-Michaluk L, Guidotti A, Krueger KE, (1988) Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands. Mol Pharmacol 34: 272-278.
7. Antkiewicz-Michaluk L, Mukhin AG, Guidotti A, Krueger KE, (1988) Purification and characterization of a protein associated with peripheral-type benzodiazepine binding sites. J Biol Chem 263: 17317-17321.
8. Anzini M, Cappelli A, Vomero S, Giorgi G, Langer T, Bruni G, et al (1996) Molecular basis of peripheral vs central benzodiazepine receptor selectivity in a new class of peripheral benzodiazepine receptor ligands related to alpidem. J Med Chem 39: 4275-4284.
9. Anzini M, Cappelli A, Vomero S, Seeber M, Menziani MC, Langer T, et al (2001) Mapping and fitting the peripheral benzodiazepine receptor binding site by carboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modeling. J Med Chem 44: 1134-1150.
10. Arlicot N, Katsifis A, Garreau L, Mattner F, Vergote J, Duval S, et al (2008) Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation. Eur J Nucl Med Mol Imaging 35: 2203-2211.
11. Arlicot N, Petit E, Katsifis A, Toutain J, Divoux D, Bodard S, et al (2010) Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE. Eur J Nucl Med Mol Imaging 37: 2371-2380.
12. Awad M, Gavish M, (1987) Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites. J Neurochem 49: 1407-1414.
13. Bakkalbasi N, Bauer K, Glover J, Wang L, (2006) Three options for citation tracking: Google Scholar, Scopus and Web of Science. Biomed Digit Libr 3: 7.
14. Banati R, Hickie IB, (2009) Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders. Med J Aust 190 (Suppl. 4): S26-S32.
15. Banati RB, (2002) Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation? J Physiol (Paris) 96: 289-299.
16. Banati RB, (2002a) Visualising microglial activation in vivo. Glia 40: 206-217.
17. Banati RB, (2003) Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain. Br Med Bull 65: 121-131.
18. Banati RB, Liu G, Middleton R, (2013) Transgenic non-human organisms with non-functional TSPO genes. In: PCT/AU2014/000250.
19. Banati RB, Middleton RJ, Chan R, Hatty CR, Kam WW, Quin C, et al (in press) Positron emission tomography and functional characterization of a complete PBR/TSPO-knockout. Nat Commun in press.
20. Banati RB, Myers R, Kreutzberg GW, (1997) PK ("peripheral benzodiazepine")-binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J Neurocytol 26: 77-82.
21. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, et al (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123 (Pt 11): 2321-2337.
22. Barabasi AL, Gulbahce N, Loscalzo J, (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12: 56-68.
23. Barron AM, Garcia-Segura LM, Caruso D, Jayaraman A, Lee JW, Melcangi RC, Pike CJ, (2013) Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease. J Neurosci 33: 8891-8897.
24. Batarseh A, Barlow KD, Martinez-Arguelles DB, Papadopoulos V, (2012) Functional characterization of the human translocator protein (18kDa) gene promoter in human breast cancer cell lines. Biochim Biophys Acta 1819: 38-56.
25. Batarseh A, Papadopoulos V, (2010) Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol Cell Endocrinol 327: 1-12.
26. Benavides J, Cornu P, Dennis T, Dubois A, Hauw JJ, MacKenzie ET, et al (1988) Imaging of human brain lesions with an omega 3 site radioligand. Ann Neurol 24: 708-712.
27. Benavides J, Quarteronet D, Imbault F, Malgouris C, Uzan A, Renault C, et al (1983) Labelling of "peripheral-type" benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J Neurochem 41: 1744-1750.
28. Bernassau JM, Reversat JL, Ferrara P, Caput D, Lefur G, (1993) A 3D model of the peripheral benzodiazepine receptor and its implication in intra mitochondrial cholesterol transport. J Mol Graph 11: 236-244, 5.
29. Besman MJ, Yanagibashi K, Lee TD, Kawamura M, Hall PF, Shively JE, (1989) Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc Natl Acad Sci USA 86: 4897-4901.
30. Blahos J 2nd, Whalin ME, Krueger KE, (1995) Identification and purification of a 10-kilodalton protein associated with mitochondrial benzodiazepine receptors. J Biol Chem 270: 20285-20291.
31. Bourdier T, Henderson D, Lam P, Fookes CJR, Mattner F, Greguric I, et al (2009) Labelling and in-vivo evaluation in baboons of a novel [11C]-carbon labelled imidazopyridine, for the study of the peripheral benzodiazepine receptors using PET. J Label Compd Radiopharm 52 (S1): S347.
32. Bourdier T, Pham TQ, Henderson D, Jackson T, Lam P, Izard M, Katsifis A, (2012) Automated radiosynthesis of [18F]PBR111 and [18F]PBR102 using the Tracerlab FXFN and Tracerlab MXFDG module for imaging the peripheral benzodiazepine receptor with PET. Appl Radiat Isot 70: 176-183.
33. Boutin H, Chauveau F, Thominiaux C, Kuhnast B, Gregoire MC, Jan S, et al (2007) In vivo imaging of brain lesions with [(11)C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors. Glia 55: 1459-1468.
34. Braestrup C, Squires RF, (1977) Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci USA 74: 3805-3809.
35. Brenner S, (2010) Sequences and consequences. Philos Trans R Soc Lond B Biol Sci 365: 207-212.
36. Bumke O, (1993) The dissolution of dementia praecox. Hist Psychiat 4: 129-139.
37. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, et al (2001) In-vivo measurement of activated microglia in dementia. Lancet 358: 461-467.
38. Cagnin A, Kassiou M, Meikle SR, Banati RB, (2006) In vivo evidence for microglial activation in neurodegenerative dementia. Acta Neurol Scand Suppl 185: 107-114.
39. Camsonne R, Crouzel C, Comar D, Mazière M, Prenant C, Sastre J, et al (1984) Synthesis of N-(11C) methyl, N-(methyl-1 propyl), (chloro-2 phenyl)-1 isoquinoleine carboxamide-3 (PK 11195): a new ligand for peripheral benzodiazepine receptors. J Label Compd Radiopharm 21: 985-991.
40. Caron KM, Soo SC, Wetsel WC, Stocco DM, Clark BJ, Parker KL, (1997) Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc Natl Acad Sci USA 94: 11540-11545.
41. Chauveau F, Boutin H, Van Camp N, Dolle F, Tavitian B, (2008) Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging 35: 2304-2319.
42. Ching AS, Kuhnast B, Damont A, Roeda D, Tavitian B, Dolle F, (2012) Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases. Insights Imaging 3: 111-119.
43. Cinone N, Hotje HD, Carotti A, (2000) Development of a unique 3D interaction model of endogenous and synthetic peripheral benzodiazepine receptor ligands. J Comput Aided Mol Des 14: 753-768.
44. Colasanti A, Guo Q, Onega M, Giannetti P, Thomas C, Piccini P, Matthews P, (2012) [F-18]PBR111 binding in multiple sclerosis: relationship to age and clinical variables. J Cereb Blood Flow Metab 32 (S1): S13-S40.
45. Corsi L, Avallone R, Geminiani E, Cosenza F, Venturini I, Baraldi M, (2004) Peripheral benzodiazepine receptors in potatoes (Solanum tuberosum). Biochem Biophys Res Commun 313: 62-66.
46. Costa B, Da Pozzo E, Chelli B, Simola N, Morelli M, Luisi M, et al (2011) Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: stimulation of in vitro neurosteroid production affecting GABAA receptor activity. Psychoneuroendocrinology 36: 463-472.
47. Cox DA, Ellinor PT, Kirley TL, Matlib MA, (1991) Identification of a 17-kDa protein associated with the peripheral-type benzodiazepine receptor in vascular and other smooth muscle types. J Pharmacol Exp Ther 258: 702-709.
48. De Souza EB, Anholt RR, Murphy KM, Snyder SH, Kuhar MJ, (1985) Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal, and testis. Endocrinology 116: 567-573.
49. Delavoie F, Li H, Hardwick M, Robert JC, Giatzakis C, Péranzi G, et al (2003) In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 42: 4506-4519.
50. Dikic B, Katsifis A, Mardon K, Mattner F, Papazian V, (1999) Imidazo[1,2-a]pyridines as peripheral benzodiazepine receptor binding agents. In: WO1999051594 A1 (PCT AU1999/000254).
51. Doble A, Ferris O, Burgevin MC, Menager J, Uzan A, Dubroeucq MC, et al (1987) Photoaffinity labeling of peripheral-type benzodiazepine-binding sites. Mol Pharmacol 31: 42-49.
52. Dollé F, Hinnen F, Damont A, Kuhnast B, Fookes C, Pham T, et al (2008) Radiosynthesis of [18F]PBR111, a selective radioligand for imaging the translocator protein (18 kDa) with PET. J Label Compd Radiopharm 51: 435-439.
53. Domazet-Loso T, Tautz D, (2008) An ancient evolutionary origin of genes associated with human genetic diseases. Mol Biol Evol 25: 2699-2707.
54. Drugan RC, Basile AS, Crawley JN, Paul SM, Skolnick P, (1986) Inescapable shock reduces [3H]Ro 5-4864 binding to "peripheral-type" benzodiazepine receptors in the rat. Pharmacol Biochem Behav 24: 1673-1677.
55. Dumont F, Waterhouse RN, Montoya JA, Mattner F, Katsifis A, Kegeles LS, Laruelle M, (2003) Synthesis and in vivo evaluation of [11C]zolpidem, an imidazopyridine with agonist properties at central benzodiazepine receptors. Nucl Med Biol 30: 435-439.
56. Eberl S, Katsifis A, Wen L, Bourdier T, Henderson D, Loc'h C, et al (2010) Quantitative analysis of the peripheral benzodiazepine receptor ligand [11C]PBR170 in baboons with PET. J Nucl Med 51 (Suppl. 2): 33.
57. Falagas ME, Pitsouni EI, Malietzis GA, Pappas G, (2008) Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J 22: 338-342.
58. Fan J, Lindemann P, Feuilloley MG, Papadopoulos V, (2012) Structural and functional evolution of the translocator protein (18 kDa). Curr Mol Med 12: 369-386.
59. Fan J, Papadopoulos V, (2012) Transcriptional regulation of translocator protein (Tspo) via a SINE B2-mediated natural antisense transcript in MA-10 Leydig cells. Biol Reprod 86: 147, 1-15.
60. Farges R, Joseph-Liauzun E, Shire D, Caput D, Le Fur G, Loison G, Ferrara P, (1993) Molecular basis for the different binding properties of benzodiazepines to human and bovine peripheral-type benzodiazepine receptors. FEBS Lett 335: 305-308.
61. Ferrarese C, Appollonio I, Frigo M, Perego M, Piolti R, Trabucchi M, Frattola L, (1990) Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment. Acta Psychiatr Scand 82: 169-173.
62. Ferrero P, Rocca P, Gualerzi A, Benna P, Enrichens F, Olivero G, et al (1991) A study of 3H-PK 11,195 binding to "peripheral-type" benzodiazepine receptors on human lymphocytes. Evidence of decreased binding in hepatic encephalopathy. J Neurol Sci 102: 209-219.
63. Fookes CJ, Pham TQ, Mattner F, Greguric I, Loc'h C, Liu X, et al (2008) Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography. J Med Chem 51: 3700-3712.
64. Fujimura Y, Zoghbi SS, Simeon FG, Taku A, Pike VW, Innis RB, Fujita M, (2009) Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06. J Nucl Med 50: 1047-1053.
65. Galiegue S, Jbilo O, Combes T, Bribes E, Carayon P, Le Fur G, Casellas P, (1999) Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor. J Biol Chem 274: 2938-2952.
66. Galperin MY, Koonin EV, (2010) From complete genome sequence to "complete" understanding? Trends Biotechnol 28: 398-406.
67. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A, (1999) Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 51: 629-650.
68. Gehlert DR, Yamamura HI, Wamsley JK, (1983) Autoradiographic localization of "peripheral" benzodiazepine binding sites in the rat brain and kidney using [3H]RO5-4864. Eur J Pharmacol 95: 329-330.
69. Ginter C, Kiburu I, Boudker O, (2013) Chemical catalysis by the translocator protein (18 kDa). Biochemistry 52: 3609-3611.
70. Giroux H, (2006) "It was such a handy term": management fashions and pragmatic ambiguity. J Manage Stud 43: 1227-1260.
71. Gray PW, Glaister D, Seeburg PH, Guidotti A, Costa E, (1986) Cloning and expression of cDNA for human diazepam binding inhibitor, a natural ligand of an allosteric regulatory site of the gamma-aminobutyric acid type A receptor. Proc Natl Acad Sci USA 83: 7547-7551.
72. Guo Q, Colasanti A, Onega M, Kamalakaran A, Pampols-Maso S, Searle G, et al (2012) Quantification of F-18-PBR111 PET for TSPO imaging in humans. J Cereb Blood Flow Metab 32 (S1): S128-S191.
73. Gut P, Baeza-Raja B, Andersson O, Hasenkamp L, Hsiao J, Hesselson D, et al (2013) Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism. Nat Chem Biol 9: 97-104.
74. Halestrap AP, (2009) What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46: 821-831.
75. Hatty CR, Le Brun AP, Lake V, Clifton LA, Liu GJ, James M, Banati RB, (2014) Investigating the interactions of the 18 kDa translocator protein and its ligand PK11195 in planar lipid bilayers. Biochim Biophys Acta 1838: 1019-1030.
76. Hauet T, Yao ZX, Bose HS, Wall CT, Han Z, Li W, et al (2005) Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria. Mol Endocrinol 19: 540-554.
77. Hirsch JD, Beyer CF, Malkowitz L, Beer B, Blume AJ, (1989) Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol Pharmacol 35: 157-163.
78. Homes TP, Mattner F, Keller PA, Katsifis A, (2006) Synthesis and in vitro binding of N,N-dialkyl-2-phenylindol-3-yl-glyoxylamides for the peripheral benzodiazepine binding sites. Bioorg Med Chem 14: 3938-3946.
79. Ikoma Y, Yasuno F, Ito H, Suhara T, Ota M, Toyama H, et al (2007) Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C]DAA1106. J Cereb Blood Flow Metab 27: 173-184.
80. James ML, Fulton RR, Henderson DJ, Eberl S, Meikle SR, Thomson S, et al (2005) Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand. Bioorg Med Chem 13: 6188-6194.
81. James ML, Selleri S, Kassiou M, (2006) Development of ligands for the peripheral benzodiazepine receptor. Curr Med Chem 13: 1991-2001.
82. Jamin N, Neumann JM, Ostuni MA, Vu TK, Yao ZX, Murail S, et al (2005) Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol Endocrinol 19: 588-594.
83. Jaremko L, Jaremko M, Becker S, Zweckstetter M, (2014) Toward the functional oligomerization state of tryptophan-rich sensory proteins. Protein Sci 23: 1154-1160.
84. Jaremko L, Jaremko M, Giller K, Becker S, Zweckstetter M, (2014) Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science 343: 1363-1366.
85. Joseph-Liauzun E, Delmas P, Shire D, Ferrara P, (1998) Topological analysis of the peripheral benzodiazepine receptor in yeast mitochondrial membranes supports a five-transmembrane structure. J Biol Chem 273: 2146-2152.
86. Katsifis A, Fookes CJR, Pham TQ, Greguric ID, Mattner MFPS, (2008) Fluorinated ligands for targeting peripheral benzodiazepine receptors. In: WO2008/022396 A1 (PCT AU2007/001216).
87. Katsifis A, Mattner F, Dikic B, Papazian V, (2000) Synthesis of substituted [123I]imidazo[1,2-α]pyridines as potential probes for the study of the peripheral benzodiazepine receptors using SPECT. Radiochimica Acta 88: 229.
88. Katsifis A, Mattner F, Mardon K, Papazian V, Dikic B, (1998) Synthesis and evaluation of I-123 imidazo 1,2-alpha pyridines as potential probes for the study of the peripheral benzodiazepine receptors using SPECT. J Nucl Med 39: 50.
89. Katsifis A, Mattner F, Zhang Z, Dikic B, Papazian V, (2000) Synthesis of [123I]N ,N -dimethyl-6-methyl-(-4 -iodophenyl)imidazo[1,2-a]pyridine-3-acetamide for the study of peripheral benzodiazepine receptors using SPECT. J Label Compd Radiopharm 43: 385-394.
90. Kelly-Hershkovitz E, Weizman R, Spanier I, Leschiner S, Lahav M, Weisinger G, Gavish M, (1998) Effects of peripheral-type benzodiazepine receptor antisense knockout on MA-10 Leydig cell proliferation and steroidogenesis. J Biol Chem 273: 5478-5483.
91. Kita A, Kohayakawa H, Kinoshita T, Ochi Y, Nakamichi K, Kurumiya S, et al (2004) Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand. Br J Pharmacol 142: 1059-1072.
92. Korkhov VM, Sachse C, Short JM, Tate CG, (2010) Three-dimensional structure of TspO by electron cryomicroscopy of helical crystals. Structure 18: 677-687.
93. Kreisl WC, Jenko KJ, Hines CS, Lyoo CH, Corona W, Morse CL, et al (2013) A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J Cereb Blood Flow Metab 33: 53-58.
94. Krueger KE, Papadopoulos V, (1990) Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J Biol Chem 265: 15015-15022.
95. Lacapere JJ, Delavoie F, Li H, Peranzi G, Maccario J, Papadopoulos V, Vidic B, (2001) Structural and functional study of reconstituted peripheral benzodiazepine receptor. Biochem Biophys Res Commun 284: 536-541.
96. Landau M, Weizman A, Zoref-Shani E, Beery E, Wasseman L, Landau O, et al (1998) Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells. Biochem Pharmacol 56: 1029-1034.
97. Landrock D, Atshaves BP, McIntosh AL, Landrock KK, Schroeder F, Kier AB, (2010) Acyl-CoA binding protein gene ablation induces pre-implantation embryonic lethality in mice. Lipids 45: 567-580.
98. Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA, et al (1999) Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp Cell Res 249: 413-421.
99. Le Fur G, Guilloux F, Rufat P, Benavides J, Uzan A, Renault C, et al (1983) Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies. Life Sci 32: 1849-1856.
100. Le Fur G, Perrier ML, Vaucher N, Imbault F, Flamier A, Benavides J, et al (1983) Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. Life Sci 32: 1839-1847.
101. Le Fur G, Vaucher N, Perrier ML, Flamier A, Benavides J, Renault C, et al (1983) Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci 33: 449-457.
102. Lenfant M, Haumont J, Zavala F, (1986) In vivo immunomodulating activity of PK 1195, a structurally unrelated ligand for "peripheral" benzodiazepine binding sites-I. Potentiation in mice of the humoral response to sheep red blood cells. Int J Immunopharmacol 8: 825-828.
103. Li H, Papadopoulos V, (1998) Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139: 4991-4997.
104. Li H, Yao Z, Degenhardt B, Teper G, Papadopoulos V, (2001) Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci USA 98: 1267-1272.
105. Li J, Burnham JF, Lemley T, Britton RM, (2010) Citation analysis: comparison of Web of Science®, Scopus™, SciFinder®, and Google Scholar. J Electron Resour Med Libr 7: 196-217.
106. Lin D, Chang YJ, Strauss JF 3rd, Miller WL, (1993) The human peripheral benzodiazepine receptor gene: cloning and characterization of alternative splicing in normal tissues and in a patient with congenital lipoid adrenal hyperplasia. Genomics 18: 643-650.
107. Lin D, Sugawara T, Strauss JF 3rd, Clark BJ, Stocco DM, Saenger P, et al (1995) Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267: 1828-1831.
108. Liu J, Li H, Papadopoulos V, (2003) PAP7, a PBR/PKA-RIalpha-associated protein: a new element in the relay of the hormonal induction of steroidogenesis. J Steroid Biochem Mol Biol 85: 275-283.
109. Lueddens HW, Newman AH, Rice KC, Skolnick P, (1986) AHN 086: an irreversible ligand of "peripheral" benzodiazepine receptors. Mol Pharmacol 29: 540-545.
110. Maaser K, Höpfner M, Jansen A, Weisinger G, Gavish M, Kozikowski AP, et al (2001) Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells. Br J Cancer 85: 1771-1780.
111. Maeda J, Suhara T, Zhang MR, Okauchi T, Yasuno F, Ikoma Y, et al (2004) Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: an imaging tool for glial cells in the brain. Synapse 52: 283-291.
112. Marangos PJ, Patel J, Boulenger JP, Clark-Rosenberg R, (1982) Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864. Mol Pharmacol 22: 26-32.
113. Mattner F, Bandin DL, Staykova M, Berghofer P, Gregoire MC, Ballantyne P, et al (2011) Evaluation of [(123)I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation. Eur J Nucl Med Mol Imaging 38: 1516-1528.
114. Mattner F, Katsifis A, Staykova M, Ballantyne P, Willenborg DO, (2005) Evaluation of a radiolabelled peripheral benzodiazepine receptor ligand in the central nervous system inflammation of experimental autoimmune encephalomyelitis: a possible probe for imaging multiple sclerosis. Eur J Nucl Med Mol Imaging 32: 557-563.
115. Mattner F, Mardon K, Loc'h C, Katsifis A, (2006) Pharmacological evaluation of an [(123)I] labelled imidazopyridine-3-acetamide for the study of benzodiazepine receptors. Life Sci 79: 287-294.
116. Mattner F, Pham T, Greguric I, Berghofer P, Ballantyne P, Liu X, et al (2007) Labelling and in vivo evaluation of the [123I] labelled Imidazopyridine-3-acetademide, CLINME for the study of the peripheral benzodiazepine binding sites. XVIIth International Symposium on Radiopharmaceutical Sciences, April 30-May 4 2007, Aachen, Germany.
117. Mattner F, Staykova M, Berghofer P, Wong HJ, Fordham S, Callaghan P, et al (2013) Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis. J Nucl Med 54: 291-298.
118. McCabe RT, Schoenheimer JA, Skolnick P, Newman AH, Rice KC, Reig J-A, Klein DC, (1989) [3H]AHN 086 acylates peripheral benzodiazepine receptors in the rat pineal gland. FEBS Lett 244: 263-267.
119. McEnery MW, (1992) The mitochondrial benzodiazepine receptor: evidence for association with the voltage-dependent anion channel (VDAC). J Bioenerg Biomembr 24: 63-69.
120. McNamara BC, Jefcoate CR, (1989) The role of sterol carrier protein 2 in stimulation of steroidogenesis in rat adrenal mitochondria by adrenal cytosol. Arch Biochem Biophys 275: 53-62.
121. Miller WL, (1997) Congenital lipoid adrenal hyperplasia: the human gene knockout for the steroidogenic acute regulatory protein. J Mol Endocrinol 19: 227-240.
122. Mizrahi R, Rusjan PM, Kennedy J, Pollock B, Mulsant B, Suridjan I, et al (2012) Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA. J Cereb Blood Flow Metab 32: 968-972.
123. Morohaku K, Pelton SH, Daugherty DJ, Butler WR, Deng W, Selvaraj V, (2014) Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology 155: 89-97.
124. Mukherjee S, Das SK, (1989) Subcellular distribution of "peripheral type" binding sites for [3H]Ro5-4864 in guinea pig lung. Localization to the mitochondrial inner membrane. J Biol Chem 264: 16713-16718.
125. Mukhin AG, Papadopoulos V, Costa E, Krueger KE, (1989) Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc Natl Acad Sci USA 86: 9813-9816.
126. Murail S, Robert JC, Coic YM, Neumann JM, Ostuni MA, Yao ZX, et al (2008) Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding. Biochim Biophys Acta 1778: 1375-1381.
127. O'Beirne GB, Woods MJ, Williams DC, (1990) Two subcellular locations for peripheral-type benzodiazepine acceptors in rat liver. Eur J Biochem 188: 131-138.
128. Oke BO, Suarez-Quian CA, Riond J, Ferrara P, Papadopoulos V, (1992) Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex. Mol Cell Endocrinol 87: R1-R6.
129. Olson JM, Ciliax BJ, Mancini WR, Young AB, (1988) Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. Eur J Pharmacol 152: 47-53.
130. Ortore G, Tuccinardi T, Martinelli A, (2012) Computational studies on translocator protein (TSPO) and its ligands. Curr Top Med Chem 12: 352-359.
131. Owen DR, Lewis AJ, Reynolds R, Rupprecht R, Eser D, Wilkins MR, et al (2011) Variation in binding affinity of the novel anxiolytic XBD173 for the 18 kDa translocator protein in human brain. Synapse 65: 257-259.
132. Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al (2012) An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab 32: 1-5.
133. Pandey R, Flockerzi D, Hauser MJ, Straube R, (2011) Modeling the light- and redox-dependent interaction of PpsR/AppA in Rhodobacter sphaeroides. Biophys J 100: 2347-2355.
134. Papadopoulos V, (1993) Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr Rev 14: 222-240.
135. Papadopoulos V, Amri H, Boujrad N, Cascio C, Culty M, Garnier M, et al (1997) Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 62: 21-28.
136. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, et al (2006) Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27: 402-409.
137. Papadopoulos V, Guarneri P, Kreuger KE, Guidotti A, Costa E, (1992) Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. Proc Natl Acad Sci USA 89: 5113-5117.
138. Papadopoulos V, Mukhin AG, Costa E, Krueger KE, (1990) The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J Biol Chem 265: 3772-3779.
139. Parisio G, Sperotto MM, Ferrarini A, (2012) Flip-flop of steroids in phospholipid bilayers: effects of the chemical structure on transbilayer diffusion. J Am Chem Soc 134: 12198-12208.
140. Parola AL, Stump DG, Pepperl DJ, Krueger KE, Regan JW, Laird HE 2nd, (1991) Cloning and expression of a pharmacologically unique bovine peripheral-type benzodiazepine receptor isoquinoline binding protein. J Biol Chem 266: 14082-14087.
141. Pastorino JG, Simbula G, Yamamoto K, Glascott PA Jr, Rothman RJ, Farber JL, (1996) The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem 271: 29792-29798.
142. Peyronneau M-A, Loc'h C, Mattner F, Pham T, Jiang C, Pellegrini P, et al (2011) In vitro metabolism of [18F]PBR102 and [18F]PBR111 in rats and humans. Eur J Nucl Med Mol Imaging 38 (Suppl. 2): S231.
143. Peyronneau M-A, Mattner F, Howell N, Jiang C, Pellegrini P, Greguric I, et al (2010) Metabolism of CLINDE, a peripheral benzodiazepine receptor SPECT ligand. Eur J Nucl Med Mol Imaging 37 (Suppl. 2):S242.
144. Peyronneau M-A, Saba W, Goutal S, Damont A, Dollé F, Kassiou M, et al (2013) Metabolism and quantification of [18F]DPA-714, a new TSPO positron emission tomography radioligand. Drug Metab Dispos 41: 122-131.
145. Pike VW, (2009) PET radiotracers: crossing the blood-brain barrier and surviving metabolism. Trends Pharmacol Sci 30: 431-440.
146. Politis M, Su P, Piccini P, (2012) Imaging of microglia in patients with neurodegenerative disorders. Front Pharmacol 3: 96.
147. Privalle CT, Crivello JF, Jefcoate CR, (1983) Regulation of intramitochondrial cholesterol transfer to side-chain cleavage cytochrome P-450 in rat adrenal gland. Proc Natl Acad Sci USA 80: 702-706.
148. Reeves C, (2003) OPINION: can rhetorical momentum influence agreement in science? Sci Newspaper Sci Prof 17: 19.
149. Riond J, Leplatois P, Laurent P, Le Fur G, Caput D, Loison G, Ferrara P, (1991) Expression and pharmacological characterization of the human peripheral-type benzodiazepine receptor in yeast. Eur J Pharmacol 208: 307-312.
150. Riond J, Mattei MG, Kaghad M, Dumont X, Guillemot JC, Le Fur G, et al (1991) Molecular cloning and chromosomal localization of a human peripheral-type benzodiazepine receptor. Eur J Biochem 195: 305-311.
151. Rupprecht R, Holsboer F, (1999) Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22: 410-416.
152. Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, et al (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 9: 971-988.
153. Rupprecht R, Rammes G, Eser D, Baghai TC, Schule C, Nothdurfter C, et al (2009) Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science 325: 490-493.
154. Schoemaker H, Bliss M, Yamamura HI, (1981) Specific high-affinity saturable binding of [3H] R05-4864 to benzodiazepine binding sites in the rat cerebral cortex. Eur J Pharmacol 71: 173-175.
155. Schoemaker H, Boles RG, Horst WD, Yamamura HI, (1983) Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney. J Pharmacol Exp Ther 225: 61-69.
156. Schoemaker H, Morelli M, Deshmukh P, Yamamura HI, (1982) 3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia. Brain Res 248: 396-401.
157. Selleri S, Bruni F, Costagli C, Costanzo A, Guerrini G, Ciciani G, et al (2005) A novel selective GABA(A) alpha1 receptor agonist displaying sedative and anxiolytic-like properties in rodents. J Med Chem 48: 6756-6760.
158. Shah F, Hume SP, Pike VW, Ashworth S, McDermott J, (1994) Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl Med Biol 21: 573-581.
159. Sileikyte J, Blachly-Dyson E, Sewell R, Carpi A, Menabò R, Di Lisa F, et al (2014) Regulation of the Mitochondrial Permeability Transition Pore by the Outer Membrane does not Involve the Peripheral Benzodiazepine Receptor (TSPO). J Biol Chem 289: 13769-13781.
160. Song PJ, Barc C, Arlicot N, Guilloteau D, Bernard S, Sarradin P, et al (2010) Evaluation of prion deposits and microglial activation in scrapie-infected mice using molecular imaging probes. Mol Imaging Biol 12: 576-582.
161. Sprengel R, Werner P, Seeburg PH, Mukhin AG, Santi MR, Grayson DR, et al (1989) Molecular cloning and expression of cDNA encoding a peripheral-type benzodiazepine receptor. J Biol Chem 264: 20415-20421.
162. Starosta-Rubinstein S, Ciliax BJ, Penney JB, McKeever P, Young AB, (1987) Imaging of a glioma using peripheral benzodiazepine receptor ligands. Proc Natl Acad Sci USA 84: 891-895.
163. Stocco DM, (2014) The role of PBR/TSPO in steroid biosynthesis challenged. Endocrinology 155: 6-9.
164. Stocco DM, Clark BJ, (1996) Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis. Biochem Pharmacol 51: 197-205.
165. Tang D, Hight MR, McKinley ET, Fu A, Buck JR, Smith RA, et al (2012) Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimi din-3-yl)acetamide. J Nucl Med 53: 287-294.
166. Tang D, Nickels ML, Tantawy MN, Buck JR, Manning HC, (2014) Preclinical Imaging Evaluation of Novel TSPO-PET Ligand 2-(5,7-Diethyl-2-(4-(2-[F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N- diethylacetamide ([ F]VUIIS1008) in Glioma. Mol Imaging Biol [online publications ahead of print].
167. Taupin V, Toulmond S, Serrano A, Benavides J, Zavala F, (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion: influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol 42: 177-185.
168. Teboul D, Beaufils S, Taveau JC, Iatmanen-Harbi S, Renault A, Venien-Bryan C, et al (2012) Mouse TSPO in a lipid environment interacting with a functionalized monolayer. Biochim Biophys Acta 1818: 2791-2800.
169. Thominiaux C, Mattner F, Greguric I, Boutin H, Chauveau F, Kuhnast B, et al (2007) Radiosynthesis of 2-[6-chloro-2-(4-iodophenyl)imidazo[1,2-a]pyridin-3-yl]-N-ethyl-N-[11C]methyl-acetamide, [11C]CLINME, a novel radioligand for imaging the peripheral benzodiazepine receptors with PET. J Label Compd Radiopharm 50: 229-236.
170. Tu LN, Morohaku K, Manna PR, Pelton SH, Butler WR, Stocco DM, Selvaraj V, (2014) Peripheral benzodiazepine receptor/translocator protein global knockout mice are viable with no effects on steroid hormone biosynthesis. J Biol Chem [online publications ahead of print].
171. Van Camp N, Boisgard R, Kuhnast B, Theze B, Viel T, Gregoire MC, et al (2010) In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [(11)C]CLINME and [(11)C]PK11195 in an acute rodent model. Eur J Nucl Med Mol Imaging 37: 962-972.
172. Veenman L, Gavish M, (2012) The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression. Curr Mol Med 12: 398-412.
173. Veenman L, Papadopoulos V, Gavish M, (2007) Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des 13: 2385-2405.
174. Verma A, Nye JS, Snyder SH, (1987) Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc Natl Acad Sci USA 84: 2256-2260.
175. Verschuer JD, Towson J, Eberl S, Katsifis A, Henderson D, Lam P, et al (2012) Radiation dosimetry of the translocator protein ligands [18F]PBR111 and [18F]PBR102. Nucl Med Biol 39: 742-753.
176. Weizman R, Tanne Z, Granek M, Karp L, Golomb M, Tyano S, Gavish M, (1987) Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients. Eur J Pharmacol 138: 289-292.
177. Wieland DM, Kilbourn MR, Yang DJ, Laborde E, Gildersleeve DL, Van Dort ME, et al (1988) NMDA receptor channels: labeling of MK-801 with iodine-125 and fluorine-18. Int J Rad Appl Instrum A 39: 1219-1225.
178. Wilson AA, Garcia A, Parkes J, McCormick P, Stephenson KA, Houle S, Vasdev N, (2008) Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nucl Med Biol 35: 305-314.
179. Winkeler A, Boisgard R, Awde AR, Dubois A, Theze B, Zheng J, et al (2012) The translocator protein ligand [(1)(8)F]DPA-714 images glioma and activated microglia in vivo. Eur J Nucl Med Mol Imaging 39: 811-823.
180. Xiao HS, Huang QH, Zhang FX, Bao L, Lu YJ, Guo C, et al (2002) Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci USA 99: 8360-8365.
181. Yeliseev AA, Kaplan S, (2000) TspO of rhodobacter sphaeroides. A structural and functional model for the mammalian peripheral benzodiazepine receptor. J Biol Chem 275: 5657-5667.
182. Yeliseev AA, Krueger KE, Kaplan S, (1997) A mammalian mitochondrial drug receptor functions as a bacterial "oxygen" sensor. Proc Natl Acad Sci USA 94: 5101-5106.
183. Zhang MR, Kida T, Noguchi J, Furutsuka K, Maeda J, Suhara T, Suzuki K, (2003) [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. Nucl Med Biol 30: 513-519.
184. Zhang MR, Ogawa M, Maeda J, Ito T, Noguchi J, Kumata K, et al (2006) [2-11C]isopropyl-, [1-11C]ethyl-, and [11C]methyl-labeled phenoxyphenyl acetamide derivatives as positron emission tomography ligands for the peripheral benzodiazepine receptor: radiosynthesis, uptake, and in vivo binding in brain. J Med Chem 49: 2735-2742.
185. Zubal G, Jennings D, Tamagnan G, Koren A, Katsifis A, Marek K, et al (2009) Initial Parkinson's and healthy control studies of 123-I CLINDE, a SPECT marker of the peripheral benzodiazepine receptor and neuroinflammation. J Nucl Med 50 (Suppl. 2): 1221.